Tianjin Lisheng Pharmaceutical Co Ltd SZSE:002393:
FY TOTAL REVENUE FROM OPERATIONS FOR TIANJIN LISHENG PHARMACEUTICAL RMB1.39 BILLION
FY PRELIM NET PROFIT AFTER EXTRAORDINARY ITEMS ATTRIBUTABLE FOR TIANJIN LISHENG PHARMACEUTICAL RMB169.1 MILLION
Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln
Earlier from Tianjin Lisheng Pharmaceutical Co., Ltd. Class A
- Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical
- Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical Co